How life science founders use LinkedIn to build commercial visibility
There is a moment that happens before almost every significant commercial conversation in life sciences that most founders never see.
A BD professional at a mid-size pharma company sees your company mentioned in a conference programme. Before agreeing to a meeting slot, she opens LinkedIn and searches your name. She looks at your profile, checks when you last posted, reads your most recent update, and forms an impression of where the company is. That impression takes about two minutes to form. It happens before you know the conversation is possible.
This is the research phase that precedes most B2B decisions. Most of B2B buying groups put their shortlist in order of preference before making first contact with any vendor. Most of that evaluation happens through exactly this kind of quiet, independent research.
Your LinkedIn presence is a significant part of what they find.
Table of contents
The difference between a company page and a personal profile
Most life science companies default to posting from the company LinkedIn page. It is the natural choice, a professional-looking account that represents the brand without requiring the founder to be personally visible, but there is more to consider.
LinkedIn’s algorithm allocates reach very differently between company pages and personal profiles. Company page content reaches only a small fraction of its followers, while personal profiles consistently and significantly outperform brand accounts in organic reach.
The reason is straightforward. People comment on posts from people. They share content from individuals they follow. They engage with a founder’s perspective on a clinical development milestone in ways they simply don’t engage with the same information posted from a brand account.
For a life science founder, this has a practical implication. The most commercially valuable LinkedIn presence for your company is your own profile. The company page serves as a professional reference point. Your personal profile is where the actual work of building recognition happens.
What the commercial research moment actually looks like
When a potential partner or investor searches for you before agreeing to a meeting, here is what they typically check.
First, they look at your headline. A headline that reads “CEO at [Company Name]” tells someone who already knows the company something. A headline that reads “CEO, [Company Name] | Developing RNA-based therapeutics for liver cancer” tells a first-time visitor what the company actually does. The difference matters in the two to three seconds someone spends deciding whether to read further.
Second, they look at your activity. A profile that last posted eight months ago, or never, sends a signal. It says the founder is not communicating publicly about the company’s progress. For a company at the seed to Series B stage, that absence raises questions that your LinkedIn presence should be answering.
Third, they read a post or two. What they find either confirms the impression they are forming or complicates it. A founder who writes clearly about what the company is working on, what has been learned, and what the next milestone is, communicates competence and transparency.
What to post, and why most founder content does not land
The content that builds genuine commercial visibility is specific, honest, and written in language that an educated professional outside your field can follow.
The most common mistake is announcing milestones without context. “We are pleased to announce the completion of our Phase I trial” tells a BD professional that something happened. It does not tell them what you learned, what it means for the programme, or what the next step is. It is easy to scroll past.
The content that builds recognition does three things. It describes what happened. It explains what it means for the company’s trajectory. It says what comes next. The difference is the difference between a press release and a conversation.
Many B2B decision-makers say thought leadership content prompted them to research a product they were not previously considering. Next to that, most of the decision-makers consider an organisation’s thought leadership more trustworthy than its marketing materials when assessing capability.
The content that creates this effect is the kind that shows your reasoning, shares something genuinely useful, and reflects the experience of building a company in this sector. That is content only you can write. It is also the content that makes a first-time visitor understand that the person behind the company knows what they are doing.
The consistency factor
A single strong post does not build commercial visibility. Recognition is built by repeated exposure over time.
Two to three posts per week is the cadence that produces meaningful results on LinkedIn over a six to twelve month period. A founder who posts twice a week for six months builds materially more commercial visibility than one who posts daily for two months and then stops. The algorithm rewards consistency. More importantly, so does human memory.
The objection most founders raise is time. Writing and publishing two posts per week feels like a significant commitment alongside everything else the company requires. The approach that works is to build a simple practice rather than treating each post as a standalone project.
A thirty-minute block once a week to write about one significant thing that happened, one thing that was learned, or one observation from a conference or a customer conversation produces more than enough raw material for two posts. The practice compounds over time. What feels like a deliberate effort at the start becomes a natural part of how you communicate.
The four elements worth optimising
If you are reviewing your LinkedIn presence with an eye toward commercial visibility, these are the four things that matter most.
Your headline. Describe the company and what it does, not just your title. A first-time visitor should understand the commercial context of the company from the headline alone.
Your About section. This is a professional narrative, not a CV. It answers the question a potential partner or investor has before they request a meeting: why should I pay attention to this person and this company?
Your recent activity. Your last ten posts form the impression a first-time visitor takes away. Are they showing progress, thoughtfulness, and commercial awareness? Or is the most recent post from three months ago announcing something without context?
Your company page. The company page should be current and consistent with your personal profile. It is the reference point someone checks after they have already decided you are worth investigating further. It should confirm, not contradict, what your personal presence communicates.
Where to start
The most common mistake is trying to do everything at once. The approach that works is to start with one post per week, treat it as a practice, and build from there.
The starting question is simple: what happened this week that a potential partner or customer would find useful or interesting to know? Scientific progress, a conference observation, a hiring decision, a reflection on a market dynamic, a question you are working through. The material is already there in the work you are doing. The LinkedIn practice is how it becomes visible to the people who need to know about it.
If you want a broader framework for building commercial visibility across all the channels that matter, our ebook ‘From complex science to commercial visibility’ covers the full picture, including how LinkedIn fits alongside your website, conference strategy, and narrative consistency.
For companies looking to build a more systematic LinkedIn presence and want support with strategy, content, and execution, our social media management service is built specifically for life science companies at this stage.
Questions or need guidance? Send us a message, we’re happy to help!
Any questions about life sciences marketing?
Let's talk!
Frequently asked questions about partnership positioning
What do pharma BD teams look for in a potential partner?
Beyond the science itself: management quality and execution track record, the strength and clarity of your IP position, your regulatory pathway, and your partnership readiness. Some of BD alliances fail due to integration friction rather than scientific issues, so operational credibility matters as much as scientific credibility.
How early should a life science company start building its partnership positioning?
Earlier than most founders expect. The prior awareness that makes direct outreach effective takes time to build through publications, conference presence, and consistent digital visibility. Starting 12 to 18 months before you want to have serious partnership conversations gives you time to build the narrative and visibility that supports it.
How important is LinkedIn for partnership development in life sciences?
More important than most founders realise. BD teams at large organisations research potential partners online before any direct engagement, and the personal LinkedIn profiles of founding team members are among the first things they check. A consistent, active presence from your leadership builds a body of evidence about your team’s expertise that supports the partnership narrative.
What is the biggest mistake companies make when pursuing partnerships?
Approaching potential partners before the positioning is in place. A cold approach from a company with an unclear narrative, an outdated website, and no visible conference presence is significantly harder to advance than a warm conversation with a company whose story the BD team already knows.
How does digital content support partnership development?
Content published on your website and shared through LinkedIn builds awareness with the scientific and BD teams at potential partners before any direct conversation. White papers, application notes, and thought leadership pieces function as pre-meeting credibility signals. Showcasing existing collaborations through your website also signals partnership experience and reduces perceived risk for potential new partners.
When does it make sense to work with a specialist agency on partnership positioning?
When you need to build a cleaner narrative, a stronger digital presence, or more consistent content output than your internal team can manage alongside everything else. A specialist life science marketing agency with experience in BD-stage companies can help you build the positioning infrastructure that makes your outreach more effective.
References
- https://6sense.com/blog/dont-call-us-well-call-you-what-research-says-about-when-b2b-buyers-reach-out-to-sellers/
